Male Reproductive Cancers Resource Center
Findings that correlate Epstein-Barr virus (EBV) status and solid tumors could mean that future cancer treatment may be guided by a patient's EBV status.
David F. Penson, MD, MPH, answers Cancer Therapy Advisor's questions on the most key recent developments in prostate cancer management.
Male Reproductive Cancers News
Although infrequent, malignancy is a cause of upper gastrointestinal bleeding that should be included on the differential diagnosis.
More Male Reproductive Cancers Resources
This fact sheet answers some common questions about prostate cancer, bone scan, and metastasis.
This fact sheet reviews current prostate cancer screening tests, guidelines, PSA, and risk factors.
This fact sheet provides information on symptoms, pain, causes, and treatments for testicular, testicle cancer.
Sign Up for Free e-newsletters
Breast Cancer Awareness Month Poll
Cancer Therapy Advisor Articles
- FDA Approves Pembrolizumab for Metastatic Non-Small Cell Lung Cancer
- Prostate Cancer Q&A With Key Opinion Leader David F. Penson, MD
- Viral MicroRNA Expression Linked to Worse Clinical Outcomes in Early Stage Malignancies
- Neutrophil, Lymphocyte Ratio May Predict Survival in Head and Neck Cancer
- Higher Than Expected "Real-World" Hospitalizations Associated With Systemic Cancer Therapy
- For Node-Positive Breast Cancer, EC-T Remains Standard Adjuvant Regimen
- Metformin Use May Improve Survival in Patients With Breast Cancer, Diabetes
- Adding Single-Dose Fosaprepitant Improves CINV Control
- No Survival Advantage Displayed With Transarterial Chemoembolization
- Upper Gastrointestinal Bleeding Secondary to Malignancy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|